Literature DB >> 26675218

The Role of Carrier Geometry in Overcoming Biological Barriers to Drug Delivery.

Carolyn Jordan, Vladimir V Shuvaev, Mark Bailey, Vladimir R Muzykantov, Thomas D Dziubla1.   

Abstract

For a variety of diseases, effective therapy is severely limited or rendered impossible due to an inability to deliver medications to the intended sites of action. Multiple barriers exist through the body, which have evolved over time to limit the migration of foreign compounds from entering the tissues. Turning toward biology as inspiration, it has been the general goal of drug delivery to create carrier strategies that mimic, in part, features of bacteria/ viruses that allow them overcome these barriers. By packaging drugs into nano and micron scale vehicles, it should be possible to completely change the biodistribution and residence times of pharmaceutically active compounds. Recently, due to advances in formulation technologies, it has become possible to control not just the material selection, surface chemistry, and/or size, but also the overall geometry and plasticity of the drug carriers. These approaches aid in the formulation of nonspherical particles such as, discs, rods, and even unique structures such as cubes and nanodiamonds. The adjustment of size and shape can be used for the aid or prevention in cellular uptake and also to overcome the vascular and mucosal barrier. In this review, we present a summary of some approaches used to control carrier shape and the impact these geometries have upon drug transport across biological barriers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26675218     DOI: 10.2174/1381612822666151216151856

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

Review 1.  Targeting therapeutics to endothelium: are we there yet?

Authors:  Raisa Yu Kiseleva; Patrick M Glassman; Colin F Greineder; Elizabeth D Hood; Vladimir V Shuvaev; Vladimir R Muzykantov
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

Review 2.  The ancillary effects of nanoparticles and their implications for nanomedicine.

Authors:  Evan P Stater; Ali Y Sonay; Cassidy Hart; Jan Grimm
Journal:  Nat Nanotechnol       Date:  2021-11-10       Impact factor: 40.523

3.  Study on the formation and properties of red blood cell-like Fe3O4/TbLa3(Bim)12/PLGA composite particles.

Authors:  Ping Li; Bing Qi; Kun Li; Junwei Xu; Meili Liu; Xuenan Gu; Xufeng Niu; Yubo Fan
Journal:  RSC Adv       Date:  2018-04-03       Impact factor: 4.036

4.  Spatially controlled assembly of affinity ligand and enzyme cargo enables targeting ferritin nanocarriers to caveolae.

Authors:  Vladimir V Shuvaev; Makan Khoshnejad; Katherine W Pulsipher; Raisa Yu Kiseleva; Evguenia Arguiri; Jasmina C Cheung-Lau; Kathleen M LeFort; Melpo Christofidou-Solomidou; Radu V Stan; Ivan J Dmochowski; Vladimir R Muzykantov
Journal:  Biomaterials       Date:  2018-09-12       Impact factor: 12.479

5.  Size and targeting to PECAM vs ICAM control endothelial delivery, internalization and protective effect of multimolecular SOD conjugates.

Authors:  Vladimir V Shuvaev; Silvia Muro; Evguenia Arguiri; Makan Khoshnejad; Samira Tliba; Melpo Christofidou-Solomidou; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2016-05-20       Impact factor: 9.776

Review 6.  Alterations in Cellular Processes Involving Vesicular Trafficking and Implications in Drug Delivery.

Authors:  Silvia Muro
Journal:  Biomimetics (Basel)       Date:  2018-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.